Enregistrement :
11
de
28
(2012-02-01
à
2012-08-03)
Politique ou Programme
Consultations on Canada's taxation policies relating to scientific research and experimental development tax credits as they apply to innovative pharmaceutical companies
Consultations on Patented Medicine Prices Review Board's Excessive Price Guidelines with regard to proposed changes to reporting requirements and methodology for determining excessive prices.
Negotiation of the Canada-European Union Free Trade Agreement with respect to provisions relating to intellectual property protection.
Proposition législative, Projet de loi ou résolution
Proposed Amendments to Canada's Food and Drugs Act (former Bill C-51) as they relate to the licencing and post-market surveillance of pharmaceuticals, consumer health products and natural health products